A new report reveals a new way in
which these "trans fats" gum up the cellular machinery
that keeps blood moving through arteries and veins.
In the August 2009 issue of the
international journal Atherosclerosis, University
of Illinois emeritus veterinary biosciences professor
Fred Kummerow reports for the first time that trans fats
interfere with more than one key enzyme in the
regulation of blood flow.
Kummerow begins by describing the two
main causes of heart disease - sudden blood clots in the
coronary arteries, and atherosclerosis, the buildup of
plaque in the arteries to the point where it interferes
with blood flow.
"The arteries of someone who dies from
atherosclerosis look like old scrub boards as a result
of the formation of plaques," Kummerow said. "They look
corrugated, and this plaque buildup continues to the
point where it will stop blood flow."
Trans fats contribute to both of these
causes of heart disease, Kummerow said.
Trans fats are made through
hydrogenation, which involves bubbling hydrogen through
hot vegetable oil, changing the arrangement of double
bonds in the essential fatty acids in the oil and
"saturating" the "unsaturated" carbon chain with
hydrogen. Because double bonds are rigid, altering them
can straighten or twist fat molecules into new
configurations that give the fats their special
qualities, such as the lower melting point of margarine
that makes it creamy at room temperature.
Kummerow, 94, has spent nearly six
decades studying lipid biochemistry, and is a long-time
advocate for a ban on trans fats in food.
While the body can use trans fats as a
source of energy for maintenance and growth, Kummerow
said, trans fats interfere with the body's ability to
perform certain tasks critical to good health. Because
these effects are less obvious, many researchers have
missed the underlying pathologies that result from a
diet that includes trans fats, he said.
Trans fats displace - and cannot
replace - the essential fatty acids linoleic acid
(omega-6) and linolenic acid (omega-3), which the body
needs for a variety of functions, including blood flow
regulation. Studies have shown that trans fats also
increase low-density lipoproteins (LDLs) in the blood, a
factor which some believe contributes to heart disease.
Trans fats are associated with
increased inflammation in the arteries. And trans fats
have been found to change the composition of cell
membranes, making them more leaky to calcium.
Inflammation, high LDL cholesterol and calcified
arteries are the signature ingredients of
atherosclerosis.
Trans fats also were shown to
interfere with an enzyme that converts the essential
fatty acid linoleic acid into arachidonic acid, which is
needed for the production of prostacyclin (a blood-flow
enhancer) and thromboxane (which regulates the formation
of blood clots needed for wound healing). While some in
the food oil industry believed this problem could be
overcome simply by adding more linoleic acid to
partially hydrogenated fats, in 2007 Kummerow's team
reported that extra linoleic acid did not overcome the
problem.
"Trans fats inhibited the synthesis of
arachidonic acid from linoleic acid, even when there was
plenty of linoleic acid available," he said.
The new study reports that in addition
to interfering with the production of arachidonic acid
from linoleic acid, trans fats also reduce the amount of
prostacyclin needed to keep blood flowing. Thus blood
clots may more easily develop, and sudden death is
possible.
According to the American Heart
Association, each year more than 330,000 people in the
U.S. die from coronary heart disease before reaching a
hospital or while in an emergency room. Most of those
deaths are the result of sudden cardiac arrest, the
Heart Association reports.
"This is the first time that trans
fatty acids have been shown to interfere with yet
another part of the blood-flow process," Kummerow said.
This study adds another piece of evidence to a long list
that points to trans fats as significant contributors to
heart disease, he said.
Kummerow believes the U.S. Food and
Drug Administration's new requirement (begun in 2006)
that trans fats be included on food labels is inadequate
and misleading. Anything less than one-half gram of
trans fats per serving can be listed as zero grams,
Kummerow said, so people are often getting the mistaken
impression that their food is trans fat-free.
"Go to the grocery store and compare
the labels on the margarines," he said. "Some of them
say zero trans fat. That's not true. Anything with
partially hydrogenated oils in it contains trans fat."
"Partially hydrogenated fats can be
made trans fat-free," Kummerow said. "The industry would
be helped by an FDA ban on trans fat that would save
labeling costs, medical costs and lives."